Human Genome Epidemiology Literature Finder
|
Records 1 - 4 (of 4 Records) |
| Query Trace: Neoplasms and DOCK2[original query] |
|---|
| Novel recurrently mutated genes and a prognostic mutation signature in colorectal cancer. Gut 2015 Apr 64 (4): 636-45. Yu Jun, Wu William K K, Li Xiangchun, He Jun, Li Xiao-Xing, Ng Simon S M, Yu Chang, Gao Zhibo, Yang Jie, Li Miao, Wang Qiaoxiu, Liang Qiaoyi, Pan Yi, Tong Joanna H, To Ka F, Wong Nathalie, Zhang Ning, Chen Jie, Lu Youyong, Lai Paul B S, Chan Francis K L, Li Yingrui, Kung Hsiang-Fu, Yang Huanming, Wang Jun, Sung Joseph J |
| A novel 4-gene prognostic signature for hypermutated colorectal cancer. Cancer management and research 2019 11 1985-1996. Ge Weiting, Cai Wen, Bai Rui, Hu Wangxiong, Wu Dehao, Zheng Shu, Hu Hangua |
| Genetic variants of DOCK2, EPHB1 and VAV2 in the natural killer cell-related pathway are associated with non-small cell lung cancer survival. American journal of cancer research 2021 11 (5): 2264-2277. Du Hailei, Liu Lihua, Liu Hongliang, Luo Sheng, Patz Edward F, Glass Carolyn, Su Li, Du Mulong, Christiani David C, Wei Qing |
| Association of a Novel DOCK2 Mutation-Related Gene Signature With Immune in Hepatocellular Carcinoma. Frontiers in genetics 2022 13 872224. Huang Yushen, Luo Wen, Chen Siyun, Su Hongmei, Zhu Wuchang, Wei Yuanyuan, Qiu Yue, Long Yan, Shi Yanxia, Wei Jinb |
- Page last reviewed:Feb 1, 2024
- Content source:

